Chemical Compound

nelfinavir

CAS Registry Number 159989-64-7

Back to search Request a Quote

Primary Record

nelfinavir

In stock: 1,704 g
Purity: 98.3 %
CAS: 159989-64-7

Compound Identifiers & Properties

CAS: 159989-64-7
PubChem CID: 64143
SMILES: CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O
Canonical SMILES: Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C

Names & Synonyms

nelfinavir
Viracept
Nelfinavir mesylate
159989-64-7
nelfinavirum
Viracept (TN)
Nelfinavir?
Nelfinavir (INN)
Nelfinavir [INN:BAN]
1ohr
Nelfinavir mesilate
HO3OGH5D7I
Nelfinavir [BAN:INN]
Nelfinavir (Standard)
SARS therapy, aRigen
UNII-HO3OGH5D7I
CHEMBL584
NELFINAVIR [MI]
RefChem:57161
C32H45N3O4S
NELFINAVIR [INN]
AG1343
NELFINAVIR [VANDF]
D08ZFL
D0L3MP
CHEBI:7496
VRX496
AG-1343
AG1343 (*Mesylate salt*)
CHEMBL1205
NELFINAVIR [WHO-DD]
Nelfinavir Monomethane Sulfonate
BIDD:PXR0143
Nelfinavir (SARS infection)
SCHEMBL38218
BDBM518
DTXSID5035080
Met-SDF-1.beta. & Nelfinavir
MLS001195634
MLS001304729
NELFINAVIR MESYLATE AG1343
BIDD:GT0395
NELFINAVIR [EMA EPAR]
NSC-747167
Viracept (TM)(*Mesylate salt*)
AC1L20J6
ARV-SR0121
orb1299514
DTXCID3015080
nelfinavir & nelfinavir mesylate
SCHEMBL29359793
GTPL11090
J05AE04
3-Bromo-1,1,1-trifluoroacetone
AG1341
AG1346
MFCD01938163
QAGYKUNXZHXKMR-HKWSIXNMSA-N
GLXC-27474
HMS2232I04
AG 1343
CID64143
Viracept (SARS infection), aRigen
ZINC3833846
BDBM50061306
C32-H45-N3-O4-S
EBC-27328
EX-A15162
HY-15287R
MFCD00931436
Nelfinavir (SARS infection), aRigen
NSC722664
NSC747167
AKOS000280862
AM84529
CS-0677
CS-O-01962
DB00220
NSC 747167
MRF-0000208
NCGC00090782-03
NCGC00090782-04
NCGC00090782-05
NCGC00090782-17
AC-20032
AC-37645
AN-31040
AS-75258
BC216005
HY-15287
LS-85417
SMR000596515
(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
A3653
B1122
FT-0631187
NS00003195
J1.642.472B
89N647
C07257
C73027
D08259
AB00698259-15
A810095
EN300-18530973
Q423366
(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide
BRD-K74117820-066-10-8
Met-Stromal Cell-derived Factor-1.beta. (Human) & Nelfinavir
(3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide
159989-65-8
1UN
2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-4-PHENYL SULFANYL-BUTYL]-DECAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID TERT-BUTYLAMIDE
3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-
NFV
NLF
(3S,4aS,8aS)-N-(tert-Butyl)-2-((2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl)decahydroisoquinoline-3-carboxamide
(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2-(2S*,3S*),3-alpha,4a-beta,8a-beta))-
N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide (3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-
3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S,4aS,8aS)-
(3S, 4aS, 8aS)-2-[(2R, 3R)-2-Hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide
(3S, 4aS, 8aS)-2-[(2R, 3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide
(3S,4abeta,8abeta)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-(2-methyl-3-hydroxybenzoylamino)-4-(phenylthio)butyl]decahydroisoquinoline-3alpha-carboxamide
(3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide; compound with methanesulfonic acid
(3S,4aS,8aS)-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide
(3S,4aS,8aS)-N-tert-butyl-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-phenylsulfanylbutyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
(3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide
(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide
(3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]decahydroisoquinoline-3-carboxamide
(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-{[(3-hydroxy-2-methylphenyl)carbonyl]amino}-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide
3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2- [(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-
3-Isoquinolinecarboxamide,1-dimethyl ethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-
3-Isoquinolinecarboxamide,1-dimethylethyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, [3S-[2(2S*,3S*),3.alpha.,4a.beta.,8a.beta.]]-